Why AI matters at this scale

Merit Medical Systems, Inc., founded in 1987 and headquartered in South Jordan, Utah, is a leading global manufacturer of disposable medical devices used in minimally invasive interventional, diagnostic, and therapeutic procedures. With a portfolio spanning cardiology, radiology, oncology, and endoscopy, Merit's products are critical for patient care worldwide. Operating at a scale of 5,000-10,000 employees, the company manages complex, high-volume manufacturing, a global supply chain for sterile goods, and stringent regulatory oversight.

At this mid-to-large enterprise size, AI transitions from a speculative tool to a strategic imperative. The scale generates vast amounts of operational data, but manual processes can no longer optimize it. AI offers the leverage needed to transform this data into competitive advantage—driving efficiency in factories that must be both high-output and flawless, optimizing logistics for perishable medical inventory, and accelerating the innovation of next-generation devices. For a company like Merit, AI is not about replacing human expertise but augmenting it to ensure unparalleled quality, reliability, and speed in a life-saving industry.

Concrete AI Opportunities with ROI

1. AI-Driven Predictive Maintenance and Yield Optimization: Manufacturing medical devices requires precision molding, extrusion, and assembly. AI models analyzing real-time sensor data from equipment can predict failures before they occur, minimizing costly unplanned downtime. Furthermore, machine learning can identify subtle correlations between process parameters and product defects, optimizing settings to improve yield. The ROI is direct: reduced capital waste, lower scrap rates, and higher overall equipment effectiveness (OEE), protecting margins on high-volume product lines.

2. Intelligent Supply Chain for Sterile Products: Merit's supply chain is uniquely challenging due to the shelf-life and sterile requirements of its products. An AI-powered demand forecasting and logistics platform can synthesize data from hospital procedure schedules, historical sales, and global shipping networks. This enables dynamic inventory management, reducing the risk of expired stock while improving fill rates for urgent orders. The financial impact includes significant reductions in write-offs from expired goods and enhanced customer satisfaction through reliable supply.

3. Accelerated R&D with Generative Design: Developing a new catheter or delivery system involves extensive prototyping and testing. Generative AI and simulation models can explore thousands of design variations for materials and geometries based on performance goals (e.g., flexibility, pressure resistance). This compresses the design cycle from months to weeks, reducing R&D costs and speeding time-to-market for innovative products. The ROI manifests as a stronger innovation pipeline and the ability to secure patents on novel, AI-optimized designs.

Deployment Risks for the 5,001-10,000 Employee Band

Implementing AI at this scale presents distinct challenges. Data Silos are common; integrating manufacturing execution systems (MES), ERP (like SAP), and quality management systems requires significant IT orchestration. Talent Acquisition is a hurdle, as competition for data scientists and ML engineers is fierce, potentially necessitating partnerships with specialized AI firms. Change Management across a global workforce of thousands requires careful planning to ensure adoption and avoid disruption to critical production lines. Finally, the Regulatory Overhead is paramount; any AI model impacting product quality or manufacturing processes must be rigorously validated and documented for FDA audits, adding layers of complexity and cost to deployment.